In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis
Galluzzo, Marco, D’Adamio, Simone, Silvaggio, Dionisio, Lombardo, Paolo, Bianchi, Luca, Talamonti, MarinaLanguage:
english
Journal:
Expert Opinion on Biological Therapy
DOI:
10.1080/14712598.2020.1708897
Date:
December, 2019
File:
PDF, 1.68 MB
english, 2019